Synthesis and biological evaluation of water-soluble esterase-activated CO-releasing molecules targeting mitochondria

Abstract Due to the beneficial effects of carbon monoxide as a cell-protective and anti-inflammatory agent, CO-releasing molecules (CORMs) offer some promising potential applications in medicine. In this context, we synthesized a set of acyloxy-cyclohexadiene-Fe(CO)3 complexes, all displaying a N-me...

Full description

Saved in:
Bibliographic Details
Main Authors: Hemmersbach, Lars (Author) , Schreiner, Yannick (Author) , Zhang, Xinmiao (Author) , Dicke, Finn (Author) , Hünemeyer, Leon (Author) , Neudörfl, Jörg-Martin (Author) , Fleming, Thomas (Author) , Yard, Benito A. (Author) , Schmalz, Hans-Günther (Author)
Format: Article (Journal)
Language:English
Published: September 6, 2022
In: Chemistry - a European journal
Year: 2022, Volume: 28, Issue: 50, Pages: 1-9
ISSN:1521-3765
DOI:10.1002/chem.202201670
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/chem.202201670
Verlag, kostenfrei, Volltext: http://chemistry.europe.onlinelibrary.wiley.com/doi/10.1002/chem.202201670
Get full text
Author Notes:Lars Hemmersbach, Yannick Schreiner, Xinmiao Zhang, Finn Dicke, Leon Hünemeyer, Jörg-Martin Neudörfl, Thomas Fleming, Benito Yard, and Hans-Günther Schmalz
Description
Summary:Abstract Due to the beneficial effects of carbon monoxide as a cell-protective and anti-inflammatory agent, CO-releasing molecules (CORMs) offer some promising potential applications in medicine. In this context, we synthesized a set of acyloxy-cyclohexadiene-Fe(CO)3 complexes, all displaying a N-methyl-pyridinium triflate moiety in the ester side chain, as mitochondria-targeting esterase-triggered CORM prodrugs. Whereas the compounds in which the acyloxy substituent is attached to the 2-position of the diene-Fe(CO)3 unit (A series) spontaneously release CO upon dissolution in phosphate buffer, which remarkably is partly suppressed in the presence of porcine liver esterase (PLE), the 1-substituted isomers (B series) show the expected PLE-induced release of CO (up to 3?equiv.). The biological activity of Mito-CORMs 2/3-B and their isophorone-derived analogs 2/3-A?, which also displayed PLE-induced CO release, was assessed by using human umbilical vein endothelial cells (HUVEC). Whereas Mito-CORMs 2/3-B were not cytotoxic up to 500??M (MTT assay), Mito-CORMs 2/3-A? caused significant toxicity at concentrations above 50??M. The anti-inflammatory potential of both Mito-CORM variants was demonstrated by concentration-dependent down-regulation of the pro-inflammatory markers VCAM-1, ICAM-1 and CXCL1 as well as induction of HO-1 in TNFα-stimulated human umbilical vein endothelial cells (HUVECs; western blotting and qPCR). Energy phenotyping by seahorse real-time cell metabolic analysis, revealed opposing shifts of metabolic potentials in cells treated either with Mito-CORMs 2/3-B (increased mitochondrial respiration and glycolytic activity) or Mito-CORMs 2/3-A? (suppressed mitochondrial respiration and increased glycolytic activity). Thus, the Mito-CORMs represent valuable tools for the safe and targeted delivery of CO to mitochondria as a subcellular compartment to induce positive anti-inflammatory effects with only minor shifts in cellular energy metabolism. Also, due to their water solubility, these compounds provide a promising starting point for further pharmacological studies.
Item Description:Online veröffentlicht: 30. Juni 2022
Gesehen am 25.09.2023
Physical Description:Online Resource
ISSN:1521-3765
DOI:10.1002/chem.202201670